Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  TSX VENTURE EXCHANGE  >  Flowr Corp    FLWR   CA34354X1087

FLOWR CORP

(FLWR)
  Report  
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Tsx Venture Exchange
06/10/2019 06/11/2019 06/12/2019 06/13/2019 06/14/2019 Date
6.63(c) 6.72(c) 6.74(c) 6.72(c) 6.85(c) Last
85 927 86 975 123 005 144 000 87 882 Volume
+7.80% +1.36% +0.30% -0.30% +1.93% Change
More quotes
Financials (CAD)
Sales 2019 23,0 M
EBIT 2019 1,20 M
Net income 2019 0,90 M
Debt 2019 -
Yield 2019 -
Sales 2020 119 M
EBIT 2020 10,0 M
Net income 2020 7,00 M
Debt 2020 -
Yield 2020 -
P/E ratio 2019 615,00
P/E ratio 2020 61,50
Capi. / Sales2019 23,9x
Capi. / Sales2020 4,63x
Capitalization 549 M
More Financials
Company
Flowr Corp, formerly known as Needle Capital Corp, is a Canada-based vertically-integrated cannabis company. The Company builds and operates Good Manufacturing Practice (GMP) compliant cultivation facilities utilizing their own growing systems. Its investment in research and development enables its... 
Sector
Pharmaceuticals
Calendar
06/25Presentation
More about the company
Latest news on FLOWR CORP
05/31FLOWR : to Participate on Cannabis Panel at the Piper Jaffray Consumer Marketpla..
AQ
05/23FLOWR : Receives NASDAQ Listing Approval
AQ
05/17FLOWR : Announces Results for the First Quarter 2019
AQ
05/11FLOWR : Completes Private Placement for Approximately C$13.5 Million
AQ
05/10FLOWR : Completes Private Placement for Approximately C$13.5 Million
AQ
04/29Flowr Provides Corporate Update
GL
04/04The Flowr Corporation Announces Results for the Fourth Quarter and Full Year ..
GL
03/28The Flowr Corporation Announces Fourth Quarter 2018 Conference Call and Webca..
GL
03/18Horizons ETFs Rebalances the Horizons Marijuana Life Sciences Index ETF
AQ
03/18Flowr Medical Cannabis Now Available to Qualified Patients Online at Shoppers..
GL
More news
Sector news : Alternative Medicine
06/15Drug Firms Sue Over Ad Rule -- WSJ
DJ
06/14Drugmakers Sue to Block Federal Rule Requiring Drug Prices in TV Ads
DJ
06/14BAYER : to Invest Billions in Weedkillers in Wake of Roundup Controversy--Update
DJ
06/14BAYER : Deutsche Bahn to Phase out Glyphosate -WirtschaftWoche
DJ
06/14BAYER : to Invest Billions in Weedkillers in Wake of Roundup Controversy
DJ
More sector news : Alternative Medicine
Chart FLOWR CORP
Duration : Period :
Flowr Corp Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 7,65  CAD
Spread / Average Target 24%
Managers
NameTitle
Tom Flow Co-Chief Executive Officer & Director
Vinay Tolia Co-Chief Executive Officer & Director
Lance Emanuel President
Steven A. Klein Chairman & Chief Strategy Officer
Alexander Dann Chief Financial Officer
Sector and Competitors
1st jan.Capitalization (M$)
FLOWR CORP56.04%451
CANOPY GROWTH CORP50.94%13 302
AURORA CANNABIS INC49.41%7 269
BEIJING TONGRENTANG CO., LTD.3.31%5 826
CRONOS GROUP INC44.30%4 534
DONG-E-E-JIAO CO LTD--.--%3 842